Biotech company closing Bothell site
Drug-discovery activities will be transferred to AMRI facilities in Singapore and its hometown of Albany, N.Y.
By Seattle Times Business staff
New York-based biotechnology researcher AMRI is closing its Bothell site, eliminating 24 jobs.
The company said Friday its drug-discovery activities will be transferred to AMRI facilities in Singapore and its hometown of Albany, N.Y.
AMRI acquired the Bothell operation in 2001. It moved into a 44,000-square-foot facility in 2009 with expectations it would “double the scale of the current operation over the next five years,” according to a company filing at the time.
AMRI, which provides contract research and development services to biotech and pharmaceutical companies, reported losses in four of the past five quarters and recently closed a research site in Hungary that had employed 100.
The Bothell closure will be complete by March 2013. After one-time charges of about $11 million, the closure will save about $2 million a year, AMRI said.